Meridian Wealth Management, LLC Aptinyx Inc. Transaction History

Meridian Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.12 - $0.69 $1,440 - $8,280	-12,000 Reduced 6.25%	180,000 $21,000
Q2 2021 Jul 22, 2021	BUY	$2.39 - $3.5 $143,400 - $210,000	60,000 Added 45.45%	192,000 $543,000
Q4 2020 Jan 19, 2021	BUY	$2.93 - $4.3 $210,960 - $309,600	72,000 Added 120.0%	132,000 $456,000
Q3 2020 Oct 09, 2020	BUY	$3.05 - $4.99 $91,500 - $149,700	30,000 Added 100.0%	60,000 $202,000
Q2 2020 Jul 15, 2020	BUY	$1.99 - $4.4 $59,700 - $132,000	30,000 New	30,000 $125,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Meridian Wealth Management, LLC with notifications on news.